Danaher logo

Danaher Share Price (NYSE: DHR)

$206.29

-1.44

(-0.69%)

Last updated on

Check the interactive Danaher Stock chart to analyse performance

Danaher stock performance

as on August 27, 2025 at 1:29 AM IST

  • Today's Low:$205.73
    Today's High:$207.79

    Day's Volatility :0.99%

  • 52 Weeks Low:$171.00
    52 Weeks High:$279.90

    52 Weeks Volatility :38.91%

Danaher Stock Returns

PeriodDanaher Corp.Sector (Health Care)S&P500
3 Months
9.91%
4.5%
11.0%
6 Months
-0.81%
-7.9%
8.1%
1 Year
-22.72%
-12.3%
14.6%
3 Years
-24.92%
7.0%
58.7%

Danaher Corp. Key Stats

Check Danaher key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$207.73
Open
$207.85
Today's High
$207.79
Today's Low
$205.73
Market Capitalization
$151.7B
Today's Volume
$2.0M
52 Week High
$279.9
52 Week Low
$171.0
Revenue TTM
$24.0B
EBITDA
$7.5B
Earnings Per Share (EPS)
$4.7
PE Ratio
45.06
Dividend Yield
0.58%
Profit Margin
14.21%
Quarterly Earnings Growth YOY
-0.37%
Return On Equity TTM
6.68%

Stock Returns calculator for Danaher Stock including INR - Dollar returns

The Danaher stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Danaher investment value today

Current value as on today

₹81,266

Returns

₹18,734

(-18.73%)

Returns from Danaher Stock

₹23,261 (-23.26%)

Dollar Returns*

₹4,527 (+4.53%)

Indian investors sentiment towards Danaher Stock

-29.17%

Period: Jul 27, 2025 to Aug 26, 2025. Change in 30 Days versus previous period

Investment in Danaher Shares from India has dropped by -29.17% over the past 30 days, indicating reduced transactional activity.

47%

Period: Jul 27, 2025 to Aug 26, 2025. Change in 30 Days versus previous period

Search interest for Danaher Stock from India on INDmoney has increased by 47% in the last 30 days, reflecting an upward trend in search activity.

Indian Mutual Funds that invest in Danaher Stock

Global Institutional Holdings in Danaher Corp.

  • Name

    Holdings %

  • Vanguard Group Inc

    8.49%

  • BlackRock Inc

    7.35%

  • State Street Corp

    3.84%

  • Wellington Management Company LLP

    2.38%

  • T. Rowe Price Associates, Inc.

    2.32%

  • Capital Research & Mgmt Co - Division 3

    2.30%

Analyst Recommendation on Danaher Stock

Rating
Trend

Buy

    73%Buy

    23%Hold

    3%Sell

Based on 30 Wall street analysts offering stock ratings for Danaher(by analysts ranked 0 to 5 stars)

Danaher Share Price Target

What analysts predicted

Upside of 19.23%

Target:

$245.95

Current:

$206.29

Danaher share price target is $245.95, a slight Upside of 19.23% compared to current price of $206.29 as per analysts' prediction.

Danaher Stock Insights

  • Price Movement

    In the last 7 days, DHR stock has moved down by -2.1%
  • Increasing Revenue

    Danaher Corp. has shown positive revenue growth over the last two quarters. The revenue increased from $5.74 billion to $5.93 billion, averaging a rise of 3.3% per quarter.
  • Decreasing Net Profit

    Danaher Corp. has been experiencing a declining trend in net profit over the last three quarters. The net profit decreased from $1.08 billion to $555 million, showing an average reduction of 27% each quarter.
  • DHR vs IDXX (1 yr)

    In the last 1 year, Idexx Laboratories, Inc. has given 32.5% return, outperforming this stock by 55.0%
  • DHR vs IDXX (3 yr)

    In the last 3 years, Idexx Laboratories, Inc. has given 83.3% return, outperforming this stock by 109.2%
  • Price to Sales

    Danaher Corp. has a Price-to-Sales Ratio of 6.2, meaning that for every $1 of sales, investors are willing to pay $6.2 for the company's stock. In comparison, for Idexx Laboratories, Inc., investors pay $12.9 for every $1 of sales, indicating that investors value Idexx Laboratories more highly relative to its sales.

Danaher Corp. Financials

Revenue
Profit
Cash Flow
Annually
Quarterly
FY19
FY20
FY21
FY22
FY23
FY24
FY24Y/Y Change
Revenue
$23.9B
↓ 0.06%
Net Income
$3.9B
↓ 17.79%
Net Profit Margin
16.33%
↓ 3.52%

Danaher Technicals Summary

Sell

Neutral

Buy

Danaher is currently in a neutral trading position according to technical analysis indicators.

Danaher Corp. Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Danaher Corp. logo
2.37%
-0.81%
-22.72%
-24.92%
1.03%
Agilent Technologies Inc. logo
-0.36%
-11.42%
-15.58%
-7.03%
19.23%
Idexx Laboratories, Inc. logo
13.24%
40.12%
32.93%
83.78%
67.06%
Thermo Fisher Scientific, Inc. logo
1.21%
-7.97%
-19.59%
-11.83%
15.63%
Iqvia Holdings Inc. logo
-4.88%
-1.49%
-24.33%
-13.79%
16.68%

Danaher Dividend announcements

  • Danaher Dividends June, 2025

    In the quarter ending June,2025. Danaher has declared dividend of $0.32

About Danaher Corp.

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. It operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment offers bioprocessing technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, and aseptic fill finish; single-use hardware, consumables, and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services for diagnostic and assay development; and healthcare filtration solutions. Its Life Sciences segment provides mass spectrometers; bioanalytical measurement systems; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies, and particle counting and characterization; genome sample preparation; microscopes; protein consumables; filtration products; and genomic medicines, such as custom nucleic acid products, and plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, GENEDATA, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX, and SCIEX brands. The Diagnostics segment offers clinical instruments, consumables, software, and services in the areas of clinical chemistry, immunoassay, hematology, and microbiology for hospitals, physicians' offices, reference laboratories, and other critical care settings. The company has a partnership with AstraZeneca PLC to develop and commercialize diagnostic tools and tests. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and
Organization
Danaher
Employees
61000
CEO
Mr. Rainer M. Blair
Industry
Instruments and Related Products Manufacturing for Measuring, Displaying, and Controlling Industrial Process Variables

Key Management of Danaher Corp.

NameTitle
Mr. Steven M. Rales
Co-Founder & Chairman
Mr. Rainer M. Blair
President, CEO & Director
Mr. Mitchell P. Rales
Co-Founder & Director
Mr. Matthew R. McGrew
CFO & Executive VP
Dr. Jose-Carlos Gutierrez-Ramos Ph.D.
Senior VP & Chief Science Officer
Mr. Brian W. Ellis J.D.
Senior VP, General Counsel & Chief Compliance Officer
Ms. Georgeann F. Couchara
Senior Vice President of Human Resources
Mr. Christopher M. Bouda
VP & Chief Accounting Officer
Mr. John Bedford
Vice President of Investor Relations
Mr. James F. O'Reilly
Senior VP, Deputy General Counsel, Secretary & Chief Sustainability Officer

Important FAQs about investing in DHR Stock from India :

What is Danaher share price today?

Danaher share price today is $206.29 as on at the close of the market. Danaher share today touched a day high of $207.79 and a low of $205.73.

What is the 52 week high and 52 week low for Danaher share?

Danaher share touched a 52 week high of $279.90 and a 52 week low of $171.00. Danaher stock price today i.e. is closed at $206.29, lower by 26.3% versus the 52 week high.

How to invest in Danaher Stock (DHR) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Danaher on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Danaher Shares that will get you 0.0073 shares as per Danaher share price of $206.29 per share as on August 27, 2025 at 1:29 AM IST.

What is the minimum amount required to buy Danaher Stock (DHR) from India?

Indian investors can start investing in Danaher (DHR) shares with as little as ₹87.6525 or $1 (as of August 27, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹876.53 in Danaher stock (as per the Rupee-Dollar exchange rate as on August 27, 2025). Based on Danaher share’s latest price of $206.29 as on August 27, 2025 at 1:29 AM IST, you will get 0.0485 shares of Danaher. Learn more about fractional shares .

What are the returns that Danaher has given to Indian investors in the last 5 years?

Danaher stock has given 1.03% share price returns and 18.61% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?

Discover More